MED19 Antikörper (AA 51-150) (Biotin)
-
- Target Alle MED19 Antikörper anzeigen
- MED19 (Mediator Complex Subunit 19 (MED19))
-
Bindungsspezifität
- AA 51-150
-
Reaktivität
- Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MED19 Antikörper ist konjugiert mit Biotin
-
Applikation
- ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Ratte
- Homologie
- Human,Mouse,Cow,Horse,Chicken
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human MED19/LCMR1
- Isotyp
- IgG
- Top Product
- Discover our top product MED19 Primärantikörper
-
anti-Mediator Complex Subunit 19 (MED19) (AA 68-117) antibody
MED19 Reaktivität: Human, Ratte, Maus, Pferd, Rind (Kuh), Kaninchen, Hund, Schwein, Affe, Fledermaus, Huhn, Hamster WB Wirt: Kaninchen Polyclonal unconjugated
anti-Mediator Complex Subunit 19 (MED19) (AA 161-188), (C-Term) antibodyMED19 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB37339 unconjugated
anti-Mediator Complex Subunit 19 (MED19) (AA 60-160) antibodyMED19 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Mediator Complex Subunit 19 (MED19) (N-Term) antibodyMED19 Reaktivität: Human, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Mediator Complex Subunit 19 (MED19) (N-Term) antibodyMED19 Reaktivität: Human, Ratte, Maus, Pferd, Rind (Kuh), Kaninchen, Hund, Meerschweinchen, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
IHC-P 1:200-400
IHC-F 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- MED19 (Mediator Complex Subunit 19 (MED19))
- Andere Bezeichnung
- MED19 (MED19 Produkte)
- Hintergrund
-
Synonyms: LCMR1, Lung cancer metastasis related protein 1, Lung cancer metastasis-related protein 1, med19, MED19_HUMAN, Mediator complex subunit 19, Mediator of RNA polymerase II transcription subunit 19, Mediator of RNA polymerase II transcription, subunit 19 homolog.
Background: MED19 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM, Oct 2008]
- Gen-ID
- 219541
- UniProt
- A0JLT2
- Pathways
- Regulation of Lipid Metabolism by PPARalpha
-
